Filter
794
Filtered Results: 794
Text search:
Drug
Prevention
and
Information
Programme
of
the
European
Union
Featured
Recommendations
61
New Publications
165
Language
Document type
No document type
462
Studies & Reports
172
Guidelines
77
Manuals
38
Strategic & Response Plan
24
Fact sheets
10
Situation Updates
6
Training Material
4
Resource Platforms
1
Countries / Regions
Western and Central Europe
79
Global
32
Eastern Europe
32
Sierra Leone
18
Ukraine
17
Myanmar / Burma
17
Africa
14
Zambia
13
Liberia
13
India
13
Kenya
11
Ethiopia
9
Eastern Europe and Central Asia
8
Uganda
8
Nigeria
7
Senegal
7
Malawi
7
Bangladesh
7
South Africa
7
Tajikistan
6
Lesotho
6
Philippines
6
Latin America and the Carribbean
6
Russia
6
Zimbabwe
5
Namibia
5
North Macedonia
4
Nepal
4
Ghana
4
Rwanda
4
Guinea
4
Cambodia
4
Asia
4
Tanzania
4
West and Central Africa
4
Middle East and North Africa
4
Georgia
4
Eswatini/ Swaziland
4
Thailand
3
Albania
3
Laos
3
Germany
3
East and Southern Africa
3
Moldova
3
Botswana
3
Burkina Faso
2
USA
2
Vietnam
2
South Sudan
2
Colombia
1
El Salvador
1
Serbia
1
Turkey
1
Benin
1
Kazakhstan
1
Syria
1
Estonia
1
Uzbekistan
1
Afghanistan
1
Peru
1
Bulgaria
1
Armenia
1
Venezuela
1
Lithuania
1
Ireland
1
Congo, Democratic Republic of
1
South–East Asia Region
1
Western Pacific Region
1
Turkmenistan
1
Denmark
1
Belarus
1
Brazil
1
Sri Lanka
1
Sudan
1
Romania
1
Poland
1
Bhutan
1
Indonesia
1
Iraq
1
Somalia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
199
Clinical Guidelines
67
Public Health
48
Pharmacy & Technologies
19
Key Resources
16
Women & Child Health
11
Capacity Building
5
Toolboxes
HIV
127
TB
126
Mental Health
105
AMR
67
COVID-19
32
Pharmacy
24
Rapid Response
20
NCDs
18
Refugee
17
Planetary Health
16
Ebola & Marburg
13
Disability
10
NTDs
10
Health Financing Toolbox
10
Global Health Education
10
Conflict
9
Caregiver
8
Polio
3
Specific Hazards
2
Natural Hazards
2
Malaria
2
Cholera
1
Social Ethics
1
Zika
1
Based on the Vulnerability Index developed in this review, an estimated 22.7 million persons in Myanmar, or 44% of the population, were found to have some form of vulnerability related to human development and/or exposure to active conflict/violence. These people experience varying combinations of p...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2...
The main objective of this guidance is to provide scientific advice, based on an evidence-based assessment of targeted public health interventions, to facilitate effective screening and vaccination for priority infectious diseases among newly arrived migrant populations to the EU/EEA. It is intended...
Formularies are lists of antibiotics that are suggested for certain healthcare settings. In developing a recommended formulary, countries should consider the needs of patients and facilities where they receive care. For example, clinicians in rural or primary health centers may need wide access to f...
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o...
Migrants in an irregular situation: access to healthcare in 10 European Union Member States
recommended
This report explores the access to healthcare granted to irregular migrants in 10 EU Member States. It focuses on migrants who are present in an irregular situation, namely those who do not fulfil conditions for entry, stay or residence. Through interviews with a range of different sources including...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 progress
Special Report
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a...
The threat posed by Zika virus infection highlights the need to reinforce preparedness arrangements for mosquito-borne diseases in EU/EEA countries, especially for pathogens transmitted by Aedes aegypti and Aedes albopictus.
The aim of this document is to highlight measures that can effectively red...
The guide is suitable and can be used for the following audiences:
1. nurses and other trained healthcare workers who can use this manual as a self-study tool and then incorporate its guidance into their practice;
2. governmental and non-governmental employers of lay and professional TB treatment ...
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
Reports of antimicrobial-resistant (AMR) microorganisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for human immunodeficiency virus (HIV) and the pathogens that cause mala...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
The Global status report on violence prevention 2014, which reflects data from 133 countries, is the first report of its kind to assess national efforts to address interpersonal violence, namely child maltreatment, youth violence, intimate partner and sexual violence, and elder abuse. Jointly publis...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
A summary of the national drug situation
A summary of the national drug situation
A summary of the national drug situation
